In an interview with CURE, Dr. Susana Campos, clinical director of the Division of Gynecologic Oncology and assistant professor of medicine at Harvard Medical School, discussed re ...

COPENHAGEN, Denmark, March 12, 2026 (GLOBE NEWSWIRE) -- Cbio A/S today announced that it has received regulatory clearance to begin a first-in-human Phase I/IIa clinical trial of novoleucel, the ...

January is Cervical Health Awareness and Cervical Cancer Screening Month – an ideal time to share the latest updates in prevention, screening and treatment for cervical cancer, the fourth most common ...

In its preliminary guidance, NICE said it had concerns about the economic model proposed by Genmab to make the case for Tivdak's use by the NHS as a second-line therapy for cervical cancer, so it was ...

Cervical cancer remains one of the most challenging diseases in oncology, with high recurrence rates and significant treatment side effects. For decades, the standard approach has relied on a ...

Cervical cancer prevention is enhanced by the HPV vaccine, reducing HPV infections that can lead to cancerous changes. Pap and HPV tests are critical tools for early detection, helping prevent ...

Circulating tumor DNA (ctDNA) levels in patients with cervical cancer before and during treatment were prognostic of disease progression and survival in a post hoc ...

A major step in prevention is the Human Papillomavirus (HPV) vaccine. While initially developed and available primarily ...

This is less than a year after the Teal Wand from Teal Health became the first at-home cervical cancer screening test approved by the U.S. Food and Drug Administration.